SINGAPORE, Dec. 1, 2014 /PRNewswire/ - Zecotek
Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of
leading-edge photonics technologies for industrial, healthcare and
scientific markets, today announced that the previously announced
new configuration of LFS scintillation crystals (LFS-3 plates) have
been successfully assessed by CERN scientists of the Large Hadron
Collider using the high energy beam upgrade. Due to the
positive results, the scientific team at CERN has ordered
additional LFS-3 plates to be integrated into modules for the main
Compact Muon Solenoid (CMS) experiment. The Company was
informed by the CERN group that the details of a qualification
contract and supply agreement will be finalized in early
2015.
"We are excited about the progress taking place at CERN and look
forward to the opportunity to have our newly configured LFS
technology used in CERN`s upgrade Large Hadron Collider," said Dr.
A.F. Zerrouk, Chairman, President,
and CEO of Zecotek Photonics Inc. "Our new LFS plates with
their new design, unique and unmatched cost performance advantages
fulfill the principle criteria necessary for higher energies to be
generated in the new LHC upgrades and CMS experiments. We are
working with our strategic partner BOET and other associates to
finalize the logistic and economic requirements to meet the
contractual requirements anticipated in early 2015."
The CMS Experiment is one of two large general-purpose particle
physics detectors built on the Large Hadron Collider at CERN in
Europe. It is composed of
three main components: scintillation material, photo-detectors and
the ubiquitous electronic system. Zecotek's new LFS-3 plates
were originally tested for use in CERN`s high energy experiments
because of their density of material, stopping power, fast decay
time, very good energy resolution, unique radiation hardness, and
competitive effective price.
In March 2013, CERN scientists
confirmed that a new subatomic particle discovered at the world's
most powerful particle accelerator is the Higgs Boson. As
CERN pushes into this new frontier of science, additional
experiments are required to determine the particle's properties and
its true form. High-energy scintillation crystals with high
radiation hardness and solid-state photo detectors are paramount
for the success of the next stage of experiments.
About the CMS Experiment at CERN
CMS is one of two
general-purpose experiments at CERN's Large Hadron Collider (LHC)
that have been built to search for new physics. CMS is designed to
detect a wide range of particles and phenomena produced in the
LHC's high-energy proton-proton and heavy-ion collisions. At
CMS, scientists are looking into the unknown and trying to answer
the most fundamental questions about our Universe, for example:
"What is the Universe really made of and what forces act within
it?" and "What gives everything substance?". CMS also
measures the properties of well-known particles with unprecedented
precision and is on the lookout for completely new, unpredicted
phenomena. Such research not only increases our understanding but
may eventually spark new technologies that could change the world
we live in. The CMS experiment is one of the largest
international scientific collaborations in history, involving 4300
particle physicists, engineers, technicians, students and support
staff from 179 universities and institutes in 41 countries.
For more information about CMS please visit
http://cms.web.cern.ch.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS;
Frankfurt: W1I) is a photonics technology company developing
high-performance scintillation crystals, photo detectors, positron
emission tomography scanning technologies, 3D auto-stereoscopic
displays, and lasers for applications in medical, high-tech and
industrial sectors. Founded in 2004, Zecotek operates three
divisions: Imaging Systems, Laser Systems and 3D Display Systems
with labs located in Canada,
Korea, Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances and joint ventures with leading industry
partners such as Hamamatsu Photonics (Japan), the European Organization for Nuclear
Research (Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), and National NanoFab Center
(South Korea). For more
information visit www.zecotek.com, follow @zecotek on Twitter.
This press release may contain forward-looking statements
that are based on management's expectations, estimates, projections
and assumptions. These statements are not guarantees of future
performance and involve certain risks and uncertainties, which are
difficult to predict. Therefore, actual future results and trends
may differ materially from what may have been stated.
The TSX Venture 50® are the top 10 companies listed on the
TSX Venture Exchange, in each of five major industry sectors –
mining, oil & gas, technology & life sciences, diversified
industries and clean technology – based on a ranking formula with
equal weighting given to return on investment, market cap growth,
trading volume and analyst coverage. All data was as of
December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.